Centro de Referencia para Lactobacilos (CERELA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), San Miguel de Tucumán, Tucumán, Argentina.
PLoS One. 2018 Jul 6;13(7):e0200426. doi: 10.1371/journal.pone.0200426. eCollection 2018.
We have demonstrated previously that a soluble factor (LrS) produced by Lactobacillus (L.) reuteri CRL 1098 modulates the inflammatory response triggered by lipopolysaccharide. In this study, the production of LrS by L. reuteri CRL 1098 was realized through two steps: i) bacterial biomass production, ii) LrS production, where the bacterial biomass was able to live but did not proliferate. Therefore, the simultaneous evaluation of the effect of different factors on the growth and LrS production was performed. Biomass production was found to be dependent mainly on culture medium, while LrS production with anti-inflammatory activity depended on culture conditions of the biomass such as pH, agitation and growth phase. The L. reuteri CRL 1098 biomass and LrS production in the optimized culture media designed for this work reduced the complete process cost by approximately 95%, respectively to laboratory scale cost.
我们之前已经证明,由鼠李糖乳杆菌(Lactobacillus reuteri)CRL1098 产生的一种可溶性因子(LrS)可调节脂多糖引发的炎症反应。在这项研究中,通过两步实现了 L. reuteri CRL1098 产生 LrS:i)细菌生物量的产生,ii)LrS 的产生,其中细菌生物量能够存活但不增殖。因此,同时评估了不同因素对生长和 LrS 产生的影响。发现生物量的产生主要取决于培养基,而具有抗炎活性的 LrS 产生则取决于生物量的培养条件,如 pH 值、搅拌和生长阶段。在为这项工作设计的优化培养基中,L. reuteri CRL1098 生物量和 LrS 的产生分别降低了实验室规模成本的约 95%和 95%,达到了实验室规模成本。